NRC Health Income Taxes Receivable, Current
NRC Health (NRC) had Income Taxes Receivable, Current of $4.33 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › and Others
us-gaap:IncomeTaxesReceivable · last filed 2026-08-04
- 2026-06-30: Income Taxes Receivable, Current $4.33M.
- 2026-03-31: Income Taxes Receivable, Current $481.00K.
- 2025-12-31: Income Taxes Receivable, Current $528.00K.
- 2025-09-30: Income Taxes Receivable, Current $0.00.
| Period end | Income Taxes Receivable, Current | Income Taxes Receivable, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.33M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $481.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $528.00K 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $438.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $141.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $141.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $645.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $283.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $34.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $161.00K 10-K · filed 2025-03-17 | |
| 2023-09-30 | $341.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $212.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $110.00K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $733.00K 10-K · filed 2024-02-27 | |
| 2022-09-30 | $386.00K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $389.00K 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $93.00K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $752.00K 10-K · filed 2023-03-03 | |
| 2021-09-30 | $95.00K 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $153.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $144.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $1.24M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $2.67M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $272.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $580.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $69.00K 10-K · filed 2021-03-05 | |
| 2019-09-30 | $556.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $637.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $217.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $348.00K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $1.00M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.71M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $68.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $375.00K 10-K · filed 2019-03-08 | |
| 2017-09-30 | $61.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.17M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $24.00K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $14.00K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $12.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $728.00K 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.92M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $157.00K 10-K · filed 2017-03-03 | |
| 2015-09-30 | $723.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $759.00K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $604.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.10M 10-K · filed 2016-03-04 | |
| 2014-09-30 | $156.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $612.00K 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $237.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $357.00K 10-K · filed 2015-03-04 | $265.00K 10-K · filed 2014-03-04 |
| 2013-09-30 | $334.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $255.00K 10-Q · filed 2013-08-08 | |
| 2012-12-31 | $158.00K 10-K · filed 2014-03-04 | |
| 2012-09-30 | $90.00K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $171.00K 10-Q · filed 2012-08-10 | |
| 2011-09-30 | $369.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $800.00K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $1.28M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |